NTHI Stock Analysis: Buy, Sell, or Hold?

NTHI - NeOnc Technologies Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$4.85
-0.04 (-0.72%) ▼
5d: -6.47%
30d: -9.27%
90d: -35.66%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 08, 2026 0d

Get Alerted When NTHI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: NTHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NTHI is currently trading at $4.84, which is considered fair relative to its 30-day fair value range of $4.50 to $5.21.

Technical Outlook: Technically, NTHI is in a strong downtrend. Immediate support is located at $4.16, while resistance sits at $5.19.

Market Sentiment: NTHI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.00 (+227.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.50 - $5.21
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 227.9% below Wall St target ($16.00)
  • CAUTION: Recommendation downgraded due to -6.5% 5-day decline

Trading Range Analysis

30-Day Trading Range $4.50 - $5.21
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $4.16
Resistance Level $5.19
Current Trend Strong Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -6.48
Wall Street Target $16.00 (+227.9%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 11:07 AM ET
Data refreshes hourly during market hours. Next update: 12:07 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
8
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yousha Neman-Ebrahim BUY 500 shares 2026-04-23
Amir F Heshmatpour BUY 10000 shares 2026-04-23
Amir F Heshmatpour BUY 10000 shares 2026-04-10

Unlock Insider Activity

See real-time buying/selling by company executives for NTHI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$833 67 BUY
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 59 HOLD
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$105 64 BUY
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 61 BUY
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 65 BUY

More Analysis for NTHI

NTHI Technical Chart NTHI Price Prediction NTHI Earnings Date NTHI Investment Advisor NTHI Fair Price Analyzer NTHI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals